As global markets react to easing inflation and shifting economic indicators, France's CAC 40 Index has shown resilience, reflecting a cautiously optimistic outlook among investors. In this context, exploring growth companies with high insider ownership on the Euronext Paris can provide insights into firms potentially well-positioned for sustained expansion amidst these evolving market conditions. Top 10 Growth Companies With High Insider Ownership In France Name Insider Ownership Earnings Growth VusionGroup (ENXTPA:VU) 13.5% 25.2% Groupe OKwind Société anonyme (ENXTPA:ALOKW) 24.8% 30.8% Adocia (ENXTPA:ADOC) 11.9% 63% Icape Holding (ENXTPA:ALICA) 30.2% 26.2% La Française de l'Energie (ENXTPA:FDE) 20.1% 31.9% Arcure (ENXTPA:ALCUR) 21.4% 27.5% S.M.A.I.O (ENXTPA:ALSMA) 17.3% 35.2% Munic (ENXTPA:ALMUN) 29.4% 149.2% MedinCell (ENXTPA:MEDCL) 16.4% 69.6% OSE Immunotherapeutics (ENXTPA:OSE) 25.6% 5.9% Click here to see the full list of 21 stocks from our Fast Growing Euronext Paris Companies With High Insider Ownership screener. Here's a peek at a few of the choices from the screener. MedinCell Simply Wall St Growth Rating: ★★★★★☆ Overview: MedinCell S.A. is a French pharmaceutical company specializing in the development of long-acting injectable medications across multiple therapeutic areas, with a market capitalization of approximately €424.28 million. Operations: The company generates its revenue primarily from the pharmaceuticals segment, totaling €11.95 million. Insider Ownership: 16.4% Revenue Growth Forecast: 43.8% p.a. MedinCell, a French biotech firm, is poised for substantial growth with an expected revenue increase of 43.8% annually. Despite recent setbacks in clinical trials, such as the Phase 3 trial for F14 not meeting its primary endpoint, there were positive secondary outcomes that could support alternative approval strategies. The company's share price remains volatile, and while currently trading below its estimated fair value, it faces challenges like shareholder dilution and a significant net loss of €25.04 million in the latest fiscal year report. Dive into the specifics of MedinCell here with our thorough growth forecast report. Upon reviewing our latest valuation report, MedinCell's share price might be too optimistic. ENXTPA:MEDCL Earnings and Revenue Growth as at Jul 2024 OVH Groupe Simply Wall St Growth Rating: ★★★★☆☆ Overview: OVH Groupe S.A. is a global provider of public and private cloud services, shared hosting, and dedicated server solutions, with a market capitalization of approximately €1.04 billion. Operations: The company generates revenue through three main segments: Public Cloud (€169.01 million), Private Cloud (€589.61 million), and Web cloud (€185.43 million). Insider Ownership: 10.5% Revenue Growth Forecast: 10.8% p.a. OVH Groupe, a French cloud services provider, is set to grow with expected profitability in three years and revenue growth forecasted at 10.8% annually, outpacing the French market's 5.7%. Despite a highly volatile share price and a forecast low return on equity of 1.7%, recent innovations like the launch of ADV-Gen3 Bare Metal servers featuring advanced AMD processors highlight its commitment to technological leadership and market responsiveness. The company’s strategic hires and product expansions indicate a focus on scaling operations sustainably while enhancing global competitiveness. Click here and access our complete growth analysis report to understand the dynamics of OVH Groupe. The analysis detailed in our OVH Groupe valuation report hints at an deflated share price compared to its estimated value. ENXTPA:OVH Earnings and Revenue Growth as at Jul 2024 VusionGroup Simply Wall St Growth Rating: ★★★★★★ Overview: VusionGroup S.A. specializes in offering digitalization solutions for commerce across Europe, Asia, and North America, with a market capitalization of approximately €2.26 billion. Operations: The company generates revenue primarily through the installation and maintenance of electronic shelf labels, contributing approximately €801.96 million. Insider Ownership: 13.5% Revenue Growth Forecast: 21.9% p.a. VusionGroup is poised for substantial growth, with earnings expected to increase by 25.2% annually, outperforming the French market's forecast of 10.9%. Despite a highly volatile share price, the company's strong insider ownership and recent technological implementations at Hy-Vee highlight its innovative edge in retail solutions. This includes real-time pricing updates and in-store fulfillment enhancements, which not only streamline operations but also offer sustainability benefits by reducing waste and operational costs. Click here to discover the nuances of VusionGroup with our detailed analytical future growth report. In light of our recent valuation report, it seems possible that VusionGroup is trading beyond its estimated value. ENXTPA:VU Earnings and Revenue Growth as at Jul 2024 Summing It All Up Click this link to deep-dive into the 21 companies within our Fast Growing Euronext Paris Companies With High Insider Ownership screener. Have a stake in these businesses? Integrate your holdings into Simply Wall St's portfolio for notifications and detailed stock reports. Simply Wall St is a revolutionary app designed for long-term stock investors, it's free and covers every market in the world. Searching for a Fresh Perspective? Explore high-performing small cap companies that haven't yet garnered significant analyst attention. Diversify your portfolio with solid dividend payers offering reliable income streams to weather potential market turbulence. Find companies with promising cash flow potential yet trading below their fair value. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.The analysis only considers stock directly held by insiders. It does not include indirectly owned stock through other vehicles such as corporate and/or trust entities. All forecast revenue and earnings growth rates quoted are in terms of annualised (per annum) growth rates over 1-3 years. Companies discussed in this article include ENXTPA:MEDCL ENXTPA:OVH and ENXTPA:VU. Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email [email protected]
Euronext Paris Growth Companies With High Insider Ownership And 10% Revenue Growth
You are reading a free article with opinions that may differ from the recommendation given by Kalkine in its paid research reports. Become a Kalkine member today to get access to our research reports, in-depth technical and fundamental research. Learn more
Start Your Free Trial Now!Download Free Report – Explore 3 Stock Ideas & Industry Insights
Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.
All investments involve risk—consider independent advice before making any investment decisions.
View 3 Research ReportsThis information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on ‘as is’ basis, using their API. The information and data provided on this page, as well as via the API, are not guaranteed to be real-time or accurate. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general informational purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine does not assume any responsibility for any trading losses you might incur as a result of using this information, data, or any analyst rating or recommendation provided. Kalkine will not accept any liability for any loss or damage resulting from reliance on the information, including but not limited to data, quotes, charts, analyst ratings, recommendations, and buy/sell signals sourced via the API.
Please be fully informed about the risks and costs associated with trading in the financial markets, as it is one of the riskiest forms of investment. Kalkine does not provide any warranties regarding the information on this page, including, without limitation, warranties of merchantability or fitness for a particular purpose or use.
Please wait processing your request...